UCLA is conducting a clinical trial to find out if an anti-inflammatory medication can help patients to stop or reduce their meth use, and improve mental functioning, by reducing toxic brain inflammation caused by meth. Counseling, study medication, and compensation are included in this 18-week outpatient clinical trial.
Interested in learning more?
Call us if you are:
18 years or older
using crystal meth
looking to stop
Call (866) 449-UCLA for information or to make an appointment at our research clinic in Hollywood or visit meth.uclasarx.org,
This UCLA research study is being conducted by the UCLA Department of Family Medicine (PI: Keith Heinzerling, M.D.) and is funded by the National Institute on Drug Abuse.